Back to results
CompletedPhase 3

Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)

NCT00575055

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Alabama Hospital (UAB)

Birmingham, Alabama, United States

+185 additional locations

View on ClinicalTrials.gov
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) — TrialFind